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Introduction
Epithelioid hemangioendothelioma (EHE) is a low-grade, 
malignant vascular neoplasm that most frequently involves 
the liver, lungs, bone, and soft tissue.1 The incidence is 
estimated to be one case per one million people.2 Despite 
commonly being a low-grade malignant tumor, one study 
found a metastasis rate of 75%.3 Treatment of choice in 
EHE with liver involvement is radical liver resection, or in 
cases with more diffuse liver involvement, liver transplan-
tation.2 Although not commonly associated with a parane-
oplastic syndrome, paraneoplastic syndromes in the setting 
of EHE have been reported.4–7
Acute disseminated encephalomyelitis (ADEM) is an 
acute, autoimmune, demyelinating disease of the central 
nervous system known to predominantly affect the white 
matter tracts of the brain and spinal cord.8 The reported inci-
dence is between 4 and 8 cases per one million people.9–11 
The disease is more common in children than adults.8,12 The 
pathogenesis is thought to occur secondary to molecular 
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Classically, there is a delay that can last up to 2 months 
after the febrile illness before the onset of the symptoms of 
ADEM. Common presenting symptoms include headache, 
nausea, emesis, fever, acute hemiparesis, mental status 
changes/encephalopathy, and gait abnormality.13,14 
Symptoms are often multifocal and rapidly progressive 
requiring hospitalization, with 15%–25% of children 
requiring intensive care unit admission.12,15 Neuroimaging 
is critical in establishing a diagnosis of ADEM. MRI is the 
imaging study of choice and abnormalities are identified on 
T2 weighted and fluid-attenuated inversion recovery 
(FLAIR) sequences as patchy areas of signal intensity, 
often with poor margins. There are typically multiple 
lesions that are large and asymmetric.8 Although ADEM 
most commonly presents after an infection or vaccination, 
multiple case reports have shown an association between 
neoplasms and ADEM presenting as a possible paraneo-
plastic syndrome.16–22
We present a case of EHE causing ADEM by a paraneo-
plastic process in a 23 year old female who presented with 
acute onset of fevers, tremors, right sided hemiplegia, 
global aphasia, and incontinence of urine and stool.
Case presentation
A 23 year old female with multifocal EHE without distant 
metastasis diagnosed by liver biopsy 10 months prior at an 
outside hospital. She presented to an outside hospital emer-
gency department complaining of severe headaches, nau-
sea, and emesis. She denied any recent sinusitis, pharyngitis, 
or upper respiratory tract infections. She denied any recent 
vaccinations. Twelve hours later, she returned to the same 
emergency department with tremors, right sided hemiple-
gia, global aphasia, and incontinence of urine and stool 
with a reported temperature 100.9°F. Head CT demon-
strated left frontal lobe hypodensity suggestive of edema 
with underlying mass. MRI of the brain (Figure 1(a)) was 
performed and showed a left frontal lobe lesion with vaso-
genic edema and midline mass effect. Initial concern was 
for intracranial mass and she was started on intravenous 
(IV) dexamethasone 4 mg every 6 hours and was transferred 
to our tertiary care center for neurosurgical evaluation.
Upon initial examination, she was alert and intermit-
tently followed one-step commands. She had dense apha-
sia, left gaze preference, bilateral papilledema, and right 
hemiplegia. A repeat MRI T2-weighted and FLAIR (Figure 
1(b)) sequence showed progression of the infiltrative lesion 
centered in the left frontal lobe with ring enhancement and 
patchy uptake within the lesion when compared to the out-
side hospital MRI. Funduscopic exam showed papilledema. 
Infectious etiology was considered given rapid progression 
of symptoms and funduscopic evidence of increased intrac-
ranial pressure. She underwent a lumbar puncture showing 
0 red blood cells, 99 white blood cells of which 93% were Figure 1. (Continued)
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neutrophils, glucose of 80 mg/dL (plasma glucose 135 mg/dL), 
and protein of 55 mg/dL. She was empirically started on 
vancomycin 1 g q12hrs, ceftriaxone 2 g q12hrs, ampho-
tericin B 10 mg/kg, micafungin 150 mg, and metronidazole 
500 mg q6hrs. MRI chest, abdomen, and pelvis with con-
trast was performed and demonstrated multiple peripher-
ally enhancing central hypo-attenuating liver lesions. She 
was scheduled to undergo a stereotactic left frontal lobe 
lesion biopsy. Before biopsy could be done, she had five to 
six generalized tonic-clonic seizures and developed a fixed 
left gaze deviation with an intermittently fixed and dilated 
4 mm left pupil. She was intubated and underwent an emer-
gent left decompressive hemicraniectomy with biopsy due 
to concern for a herniation syndrome. Operative findings 
showed no evidence of purulent or fibrous material on the 
brain suggestive of infection. A large wedge resection of 
the left frontal area was made and specimens were sent for 
pathology evaluation. Repeat brain MRI post-operatively 
showed persistent FLAIR hyperintensity in the left frontal 
lobe with heterogeneous, incomplete peripheral enhance-
ment and extension of the hyperintensity across the corpus 
callosum in to the right frontal lobe (Figure 1(c)).
Pathology of the left frontal subcortical white matter 
showed multiple foci of perivascular chronic inflammation 
with pallor and aggregates of macrophages which were con-
sistent with a demyelinating disorder (Figure 2). Given these 
results, concern for an infectious process was less likely and 
all antimicrobials and antifungals were discontinued. CSF 
gram stain, bacterial, and fungal cultures were negative. 
Blood cultures were negative and a transthoracic echocardio-
gram was negative for any evidence of vegetation. Viral 
titers including herpes simplex virus, Epstein-Barr virus, 
varicella zoster virus, and cytomegalovirus were negative. 
Serology for CSF VDRL, Lyme disease, Histoplasma, 
Toxoplasma, and Bartonella were negative. HIV-1/2 anti-
bodies and RPR were negative. Urine Histoplasma antigen 
was negative. CSF cytology was notable for a marked acute 
inflammation without evidence of malignancy. Additionally, 
CSF flow cytometry did not identify any malignant cells. No 
oligoclonal bands were present in the patient’s CSF. Given 
the patient’s negative workup, the source of her demyelina-
tion was thought to be ADEM.
The patient was given IV methylprednisolone 1 g daily 
for 5 days for immunosuppression and was then started on 
daily prednisone and sirolimus for chronic immunosuppres-
sion. Records from outside hospital were obtained in order to 
determine etiology of multiple liver lesions seen on CT 
imaging. Outside records revealed that 10 months prior the 
patient was admitted to an outside hospital for intractable 
emesis and diarrhea. Abdominal CT at that time demon-
strated pancolitis with multiple hepatic lesions. At that time, 
she underwent a liver biopsy demonstrating EHE (Figure 3) 
but the patient was lost to follow-up. Given the outside 
records, imaging of hepatic lesions, and newly diagnosed 
ADEM on brain biopsy this admission, there was concern for 
a hepatic EHE with paraneoplastic features. PET scan was 
negative for metastatic disease but did show hypermetabolic 
and hypoattenuating lesions in the liver consistent with 
known EHE. Blood tests revealed normal levels of carci-
noembryonic antigen, and cancer antigen 125. Autoimmune 
encephalopathy panel and a paraneoplastic autoantibody 
panel were negative. LGI1-IgG, CASPR2-IgG, NMO/
AQP4, and MOG-IgG1 were negative.
MRI of the liver and abdomen were performed to deter-
mine anatomic disease burden and to guide further treatment 
with possible ablation, resection, or liver transplantation. 
MRI of the liver showed 25 hyperintense diffusion restrict-
ing and peripheral rim-enhancing lesions involving all lobes 
of the liver. Given the multilobar involvement, she was not a 
candidate for ablation or resection.
She was continued on prednisone for immunosuppres-
sion for 5 weeks with therapeutic dosing of sirolimus (12–
16 ng/mL). Over the course of 3 weeks, her aphasia 
significantly improved and she regained full functional 
strength of her right upper and lower extremity with physi-
cal, occupational, and speech therapy while admitted to an 
acute inpatient rehabilitation service. She is scheduled to 
undergo a liver transplantation in hopes for a definitive 
treatment for her EHE.
Discussion
EHE is a rare tumor derived from endothelial cells that can 
involve different organs and soft tissues but the most fre-
quent topography is the liver and lungs. Various causative 
agents have been theorized to be risk factors such as vinyl 
chloride, oral contraceptives, and polyurethane based prod-
ucts.2,23 However, no definitive correlation between develop-
ment of EHE and these risk factors has been found.2 EHE is 
a diagnosis that requires imaging to locate and even then, a 
diagnosis cannot truly be made without a tissue sample.
ADEM is typically a monophasic, inflammatory, auto-
immune, CNS demyelinating disease. The presentation of 
neurological symptoms is variable, but the most common 
symptoms include headache, nausea, emesis, fever, acute 
Figure 1. (a) Initial Brain MRI Axial T2 FLAIR images 
demonstrating a large infiltrative FLAIR hyperintensity centered 
within the left frontal lobe with heterogeneous, incomplete 
peripheral enhancement and extension along the corpus 
callosum into the right frontal lobe. There were no diffusion 
restricting correlations, (b) Repeat Brain MRI Axial T2 FLAIR 
2 days after initial brain MRI demonstrating interval progression 
of the large infiltrative FLAIR hyperintensity within the left 
frontal lobe with heterogeneous, incomplete peripheral 
enhancement and extension along the corpus callosum into 
the right frontal lobe, and (c) Repeat Axial T2 FLAIR after left 
hemicraniectomy and brain biopsy. There is persistent FLAIR 
hyperintensity within the left frontal lobe with heterogeneous, 
incomplete peripheral enhancement and extension along the 
corpus callosum into the right frontal lobe. There are residual 
blood products within the biopsy cavity.
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hemiparesis, mental status changes/encephalopathy, and 
gait abnormality.13,14 Typically, the diagnosis of ADEM can 
be made without biopsy since the radiographic picture is 
characteristic with MRI T2-FLAIR sequences demonstrat-
ing patchy, poorly marginated areas of increased signal 
intensity. Due to concern for possible underlying brain 
lesion, our patient underwent a brain biopsy. Thus, the 
diagnosis of ADEM was aided by histopathology showing 
lesions with perivenular infiltrates of macrophages and foci 
of demyelination with axonal preservation on H&E, LPB-
PAS, CD68/CD163, and neurofilament immunostain.
Although EHE is not typically associated with paraneo-
plastic syndrome, multiple case reports have described a 
paraneoplastic syndromes as a result of EHE. The most 
commonly reported paraneoplastic syndrome associated 
with EHE is secondary hypertrophic osteoarthropathy. 
Figure 3. Liver histology: (a) H&E ×60: the biopsy of the liver shows complete replacement of the parenchyma with loosely 
cohesive cords and singly dispersed cells with rounded to irregular nuclei, and moderate amount of eosinophilic cytoplasm are 
dispersed in a hyalinized stroma and (b) ERG ×60: marker for vascular differentiation including benign and malignant vascular 
tumors neoplasms such as hemangioendothelioma.
Figure 2. Lesion frontal lobe histology: (a) H&E: perivenous foci of palor and demyelination, collections of inflammatory cells 
and macrophages, (b) LFB-PAS: patchy perivascular demyelination with numerous fragments of myelin debris in macrophages, (c) 
CD68 and CD163: Myelin pallor and inflammatory cells showing demyelination with relative axon preservation accompanied by 
macrophages and a microglial and mononuclear cell infiltrate, and (d) Neurofilament: relatively well preserved axons in areas of 
demyelination.
Aktas et al. 5
Secondary hypertrophic osteoarthropathy is a paraneoplas-
tic syndrome characterized by digital clubbing, periosteal 
reactions, polyarthralgia, arthritis, and synovitis.24 
Hypertrophic osteoarthropathy is commonly associated 
with pulmonary carcinomas and has been observed in pri-
mary EHE of the lungs6 as well as hepatic EHE with metas-
tasis to the lungs.7 Additional paraneoplastic syndromes 
have also been attributed to EHE. Boukhris et al.4 describe 
a case of a man with hypercalcemia related to tumor pro-
duction of PTH-rp who was ultimately diagnosed with 
EHE. Additionally, El Mahou et al.5 describe a case of a 
patient with a 13-year history of Cushing’s syndrome of 
unknown etiology despite extensive workup and hypophy-
sectomy. However, after the discovery, diagnosis, and sur-
gical excision of EHE, the patient’s hypercortisolism 
resolved and ACTH levels promptly normalized. Although 
paraneoplastic syndrome associated with EHE is uncom-
mon, there are multiple reported examples in the literature. 
Therefore, it is possible that EHE was associated with a 
paraneoplastic process in this patient.
Our patient had no antecedent febrile illness, respiratory 
infection, or vaccination to serve as a more likely cause of 
her ADEM. Although the patient’s paraneoplastic antibody 
panel was negative, no specific antibody associated with 
paraneoplastic ADEM has been successfully isolated.16 
Thus, a negative paraneoplastic panel would not rule out 
paraneoplastic syndrome, but rather fail to identify any 
paraneoplastic syndrome associated with the tested anti-
bodies. Negative paraneoplastic panels have also been 
observed in other cases of suspected paraneoplastic syn-
drome.22 Further, as above, EHE has been described to 
cause paraneoplastic disease and there are numerous reports 
suggesting demyelination as a result of paraneoplastic syn-
drome.16–22 Although a causal relationship cannot be estab-
lished at this time, we believe that the two processes in this 
patient are related, likely via a paraneoplastic syndrome, 
rather than by chance association. As an outpatient, the 
patient continues to follow up with regarding management 
of her EHE as well as a potential liver transplant.
In this report, we have described a patient with no other 
confounding medical co-morbidities who developed 
ADEM 10 months after being diagnosed EHE. To our 
knowledge and after review of the literature, we believe 
that this represents a rare presentation of ADEM by a para-
neoplastic processes from untreated EHE.
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